Sectoral Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,850
Closed -$198K 104
2025
Q1
$198K Buy
2,850
+650
+30% +$53.7K 0.15% 71
2024
Q4
$189K Hold
2,200
0.13% 78
2024
Q3
$262K Buy
+2,200
New +$293K 0.15% 83
2017
Q2
Sell
-434,960
Closed -$7.46M 67
2017
Q1
$7.46M Sell
434,960
-37,800
-8% -$658K 0.87% 34
2016
Q4
$8.48M Sell
472,760
-417,990
-47% -$7.58M 0.94% 30
2016
Q3
$18.5M Buy
890,750
+458,400
+106% +$11.4M 1.82% 24
2016
Q2
$11.6M Hold
432,350
1.2% 30
2016
Q1
$11.7M Sell
432,350
-121,800
-22% -$3.26M 0.57% 43
2015
Q4
$16.1M Buy
554,150
+83,400
+18% +$2.31M 0.69% 40
2015
Q3
$12.8M Buy
470,750
+35,800
+8% +$1.01M 0.58% 42
2015
Q2
$11.9M Buy
434,950
+45,400
+12% +$1.28M 0.5% 49
2015
Q1
$10.4M Buy
389,550
+18,980
+5% +$437K 0.39% 51
2014
Q4
$7.84M Buy
370,570
+76,200
+26% +$1.7M 0.35% 48
2014
Q3
$7.01M Buy
294,370
+35,350
+14% +$813K 0.3% 53
2014
Q2
$5.98M Sell
259,020
-14,200
-5% -$314K 0.25% 54
2014
Q1
$6.24M Buy
273,220
+71,960
+36% +$1.53M 0.26% 51
2013
Q4
$3.72M Buy
201,260
+3,500
+2% +$61K 0.16% 52
2013
Q3
$3.35M Buy
197,760
+29,750
+18% +$500K 0.16% 52
2013
Q2
$2.6M Buy
+168,010
New +$2.8M 0.08% 54

Other funds holding NVO

Sectoral Asset Management's NVO Position: Q2 2025 in Review

Sectoral Asset Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 2,850 shares — an estimated $198K sold.

Sectoral Asset Management first reported a position in NVO in Q2 2013 and held it in 19 quarters. The position peaked at $18.5M in Q3 2016. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Sectoral Asset Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Sectoral Asset Management sold 2,850 Novo Nordisk shares in Q2 2025, an estimated $198K.
  • Sectoral Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 19 quarters.
  • Sectoral Asset Management's Novo Nordisk position peaked at $18.5M in Q3 2016.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Sectoral Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.